12/18: Multi-week swing thesis based on strong daily base and post-FDA-news accumulation. Price is consolidating above heavy volume with rising daily structure, suggesting absorption rather than distribution. $1 compliance dynamics and strong cash position add tailwinds. Entry ~0.87, risk defined at loss of LOD (~0.82–0.83). Targets 1.00–1.05 initially, with potential extension toward 1.20+ if daily trend holds. Trade is managed on daily structure, not intraday noise. Exit: had to cut this trade